Transitioning historically inpatient chemotherapy regimens for hematologic malignancies to the ambulatory care setting.

Am J Health Syst Pharm 2018 Nov 21;75(22):1824-1830. Epub 2018 Aug 21.

Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, NC.

Download full-text PDF

Source
http://dx.doi.org/10.2146/ajhp180060DOI Listing
November 2018

Publication Analysis

Top Keywords

chemotherapy regimens
4
regimens hematologic
4
malignancies ambulatory
4
hematologic malignancies
4
ambulatory care
4
inpatient chemotherapy
4
care setting
4
transitioning historically
4
historically inpatient
4
care
1
setting
1
ambulatory
1
hematologic
1
inpatient
1
chemotherapy
1
regimens
1
transitioning
1
malignancies
1

Similar Publications

Making moves: Transitioning R-EPOCH to the ambulatory setting.

J Oncol Pharm Pract 2018 Dec 7;24(8):617-622. Epub 2017 Aug 7.

Pharmacy Department, Froedtert & The Medical College of Wisconsin, Milwaukee, WI, USA.

Purpose: Ambulatory administration of chemotherapy provides benefit to patients and institutions alike. We hypothesized that transitioning rituximab, etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin (R-EPOCH) from an inpatient to ambulatory setting would reduce inpatient bed days and overall healthcare costs. The purpose of this effort was to create a guideline that would transition R-EPOCH to the ambulatory setting. Read More

View Article and Full-Text PDF
December 2018

Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).

J Am Vet Med Assoc 2011 Feb;238(4):501-6

The Animal Medical Center, 510 E 62nd St, New York, NY 10065, USA.

Objective: To evaluate factors associated with second remission in dogs with lymphoma retreated with a cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) protocol after relapse following initial treatment with a first-line 6-month CHOP protocol.

Design: Retrospective case series.

Animals: 95 dogs with lymphoma. Read More

View Article and Full-Text PDF
February 2011

Bilateral Endobronchial Masses and Severe Hypoxemic Respiratory Failure.

J Bronchology Interv Pulmonol 2019 10;26(4):e65-e67

Department of Medicine, Division of Pulmonary and Critical Care Medicine.

View Article and Full-Text PDF
October 2019

Reducing Hospitalizations: Institution of Outpatient Infusional EPOCH-Based Chemotherapy at a Safety Net Hospital.

J Oncol Pract 2019 08 17;15(8):e644-e651. Epub 2019 Jun 17.

1University of Texas Southwestern Medical Center, Dallas, TX.

Purpose: EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) -based chemotherapy is traditionally administered inpatient because of its complex 96-hour protocol and number of involved medications. These routine admissions are costly, disruptive, and isolating to patients. Here, we describe our experience transitioning from inpatient to outpatient ambulatory EPOCH-based chemotherapy in a safety-net hospital, associated cost savings, and patient perceptions. Read More

View Article and Full-Text PDF
August 2019